- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT04665401
Personalizing Interventions Using Real-World Interactions
Personalizing Interventions Using Real-World Interactions: Improving Symptoms and Social Functioning in Schizophrenia With Tailored Metacognitive Therapy
Social functioning deficits are among the most disabling and difficult to treat aspects of schizophrenia. An essential component of social functioning is metacognition-a process that is profoundly disrupted in schizophrenia and represents the ability to reflect upon the mental states of oneself and others. To date, treatment efforts in schizophrenia have been hindered by barriers in accurately monitoring client's real-world social interactions. Recently, wearable technologies have evolved to provide therapists with innovative, ecologically-valid tools. The Electronically Activated Recorder is a wearable audio recorder that collects behavioral samples at pre-programmed intervals; it holds great promise as a method for yielding concrete, real-world examples of social interactions that can be used by therapists in session to enhance metacognition. Despite the immense costs of social functioning deficits, no previous studies have investigated whether functioning can be improved by integrating wearable audio recorders with psychosocial interventions.
By enhancing therapy using a wearable recording device, this proposal's primary goal is to implement a novel intervention that targets metacognitive deficits to improve social functioning. The novel intervention will be tailored to individual clients-based on the content of recorded social interactions-in a way that is not possible using traditional psychotherapy. This will allow clients and therapists to step out of the therapy room by offering a window into how clients process material in real-world interactions. In this study, a randomized controlled trial will be conducted with two schizophrenia groups receiving six months of individualized: 1) Metacognition Reflection and Insight Therapy (MERIT) alone (Standard MERIT); and 2) Tailored MERIT using wearable audio recorders. In this study, our specific aims will test feasibility, effectiveness, and acceptability of Tailored MERIT.
Aperçu de l'étude
Statut
Intervention / Traitement
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Positive screen for metacognitive dysfunction
- Serious Mental Illness diagnosis (schizophrenia-spectrum)
- Age 18-60
- English fluency
- Currently in non-acute phase of illness
Exclusion Criteria:
- Inability to provide informed consent
- Current substance dependence
- Documented intellectual disability
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Comparateur actif: Standard MERIT
24 sessions of Metacognition Reflection and Insight Therapy
|
see arm description
|
|
Expérimental: Tailored MERIT
24 sessions of personalized Metacognition Reflection and Insight Therapy (sessions personalized using real-world interactions)
|
see arm description
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Global Functioning Scale: Social (GFS)
Délai: Change from baseline social functioning to social functioning after 6 months of MERIT
|
10-point measure of social functioning (1 to 10, with increasing scores indicating greater social functioning)
|
Change from baseline social functioning to social functioning after 6 months of MERIT
|
|
Metacognitive Beliefs Questionnaire-Brief (MCQ-30)
Délai: Change from baseline metacognition to metacognition after 6 months of MERIT
|
30 item measure of metacognition; each item is rated on a 1 to 4 scale with decreasing scores representing better metacognitive functioning.
|
Change from baseline metacognition to metacognition after 6 months of MERIT
|
|
The Positive and Negative Syndrome Scale (PANSS)
Délai: Change from baseline symptoms to symptoms after 6 months of MERIT
|
30 item measure of symptoms; each item is rated 1 to 7, with greater scores representing more severe symptoms (and lower scores indicating better functioning)
|
Change from baseline symptoms to symptoms after 6 months of MERIT
|
|
EAR Adherence
Délai: Average of EAR adherence from baseline and 6 month assessment sessions
|
Objective measure of how often EAR was worn; 0 (not worn) and 1 (worn) scores given at each of 48 potential time points.
Total score represents frequency that the EAR is worn across all time points.
|
Average of EAR adherence from baseline and 6 month assessment sessions
|
|
EAR Experiential Questionnaire
Délai: Average of EAR acceptability from baseline and 6 month assessment sessions
|
Assessment of how acceptable wearing the EAR was and how typical days were that EAR was worn.
Scores for each item range from 1 to 5 with greater scores indicating greater problems (and lower acceptability).
|
Average of EAR acceptability from baseline and 6 month assessment sessions
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Quality of Life Scale
Délai: Change from baseline quality of life to quality of life after 6 months of MERIT
|
21 item measure of quality of life; each item is rated from 0 to 6, with greater scores indicating greater quality of life.
|
Change from baseline quality of life to quality of life after 6 months of MERIT
|
|
Metacognition Assessment Scale- Abbreviated (MAS-A)
Délai: Change from baseline metacognitive capacity to metacognitive capacity after 6 months of MERIT
|
Clinician-rated measure of metacognition using a semi structured clinical interview; four areas of capacity are rated (0 to 28 on overall scale); for each, increasing scores represent greater capacity.
|
Change from baseline metacognitive capacity to metacognitive capacity after 6 months of MERIT
|
|
Short Form Health Survey (SF-36
Délai: Change from baseline functioning to functioning after 6 months of MERIT
|
36 item measure of social functioning and general health behaviors; each item on a different scale but greater scores indicate better overall functioning.
|
Change from baseline functioning to functioning after 6 months of MERIT
|
|
Objective Behaviors from the Electronically Activated Recorder
Délai: Baseline, 3 months into MERIT, 6 months into MERIT (MERIT completed)
|
EAR coding can be implemented to rate different forms of objective behaviors; codes generated using different scales but primarily use a 0 (not present) or 1 (present) coding scheme.
Greater scores typically represent presence of that which is being coded.
|
Baseline, 3 months into MERIT, 6 months into MERIT (MERIT completed)
|
|
Scale to Assess Unawareness of Mental Disorder
Délai: Baseline, 3 months into MERIT, 6 months into MERIT (MERIT completed)
|
Insight measure; three items rated on 1 to 5 scale, with increasing scores indicating poorer insight.
|
Baseline, 3 months into MERIT, 6 months into MERIT (MERIT completed)
|
Collaborateurs et enquêteurs
Parrainer
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- MERIT EAR Study
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .